BridgeMD
New treatment option for Stuttering, Developmental
Official title Investigating Individual Differences in Speech Motor Skills in Neurotypical Speakers and Persons With Disordered Speech
ClinicalTrials.gov ID: NCT07459803
What this study is testing
- What it's testing
- This study aims to understand how people use different types of feedback to control their speech. When an individual speaks, the brain relies on several systems at the same time, such as sensory systems that monitor an individuals own voice and the movements of their speech muscles, and a motor system that builds and reads out learned motor patterns.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 50. Healthy volunteers may be eligible.
You may be able to join if
- Native speakers of American English
- Adults age 18-50
- Age-appropriate cognitive and receptive vocabulary skills
- Age-appropriate hearing
- Adults with dyslexia will have a history of dyslexia or report of ongoing reading difficulties that will be confirmed at the first screening visit
You likely can't join if
- History of neurological disorder, including a history of seizures
- Major brain injury, brain surgery, or stroke
- Orthodontia or atypical oral structure (e.g., cleft palate) that interferes with speech
- Fluency disorder (except those in the persons who stutter cohort), apraxia of speech, or dysarthria
- Language or reading disorder (except those in persons with dyslexia cohort)
- Standardized score below 80 on the Kaufman Brief Intelligence Test
See the full eligibility criteria
- Native speakers of American English
- Adults age 18-50
- Age-appropriate cognitive and receptive vocabulary skills
- Age-appropriate hearing
- Adults with dyslexia will have a history of dyslexia or report of ongoing reading difficulties that will be confirmed at the first screening visit
- Adults who stutter will have a history of stuttering that will be confirmed at the first screening visit
- History of neurological disorder, including a history of seizures
- Major brain injury, brain surgery, or stroke
- Orthodontia or atypical oral structure (e.g., cleft palate) that interferes with speech
- Fluency disorder (except those in the persons who stutter cohort), apraxia of speech, or dysarthria
- Language or reading disorder (except those in persons with dyslexia cohort)
- Standardized score below 80 on the Kaufman Brief Intelligence Test
- Standardized score below 1 standard deviation on the NIH Toolbox Picture Vocabulary Test
- Pregnancy
- Severe claustrophobia
- Presence of magnetically or mechanically active implant, or other ferromagnetic material embedded in any part of the body
- Significant scalp lesions that would prevent transcranial direct stimulation
The study team makes the final eligibility decision.
Where it's taking place
- Boston, Massachusetts, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 50 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Boston, Massachusetts, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.